ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 172 out of 780

$4.67M Total Retail Price of All Prescriptions

Rank: 1 out of 780

361 Patients Receiving at Least One Drug in Part D
20%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 361 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 361 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 1,552 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$339 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
NORVIR 763 57 1 202
LISINOPRIL 622 87 2 6
PREZISTA 563 54 3 227
CRESTOR 560 106 4 32
TRUVADA 544 17 5 217
ISENTRESS 443 31 6 245
AMLODIPINE BESYLATE 438 58 7 4
ATRIPLA 417 28 10 8 231
EPZICOM 294 52 9 282
HYDROCODONE-ACETAMINOPHEN 287 61 S3 10 1
OMEPRAZOLE 280 31 11 3
TRAMADOL HCL 256 0 12 15
MELOXICAM 247 35 13 16
HYDROCHLOROTHIAZIDE 201 51 14 10
SUSTIVA 197 18 10 15 286
IBUPROFEN 192 0 16 93
TRIAMTERENE-HCTZ 178 19 17 37
PRAVASTATIN SODIUM 174 0 18 9
KALETRA 171 0 19 308
REYATAZ 170 0 20 291
METFORMIN HCL 164 13 21 8
VIREAD 162 11 22 342
NEXIUM 154 27 23 22
CYCLOBENZAPRINE HCL 149 0 R 24 42
LAMIVUDINE-ZIDOVUDINE 146 0 10 25 288
SULFAMETHOXAZOLE-TRIMETHOPRIM 134 0 26 88
AMITRIPTYLINE HCL 130 12 R 27 48
GABAPENTIN 123 0 28 13
ACTOS 113 26 29 144
ACYCLOVIR 110 0 30 320
RANITIDINE HCL 109 18 31 39
TRIZIVIR 109 11 10 31 379
PROAIR HFA 106 0 33 62
AZITHROMYCIN 106 0 33 38
FLUCONAZOLE 105 0 35 111
FOSINOPRIL SODIUM 105 32 35 112
COMBIVIR 104 0 10 37 382
FUROSEMIDE 93 23 38 7
BACLOFEN 87 18 39 153
KETOCONAZOLE 84 0 40 285
DOXAZOSIN MESYLATE 81 0 41 97
CITALOPRAM HBR 76 0 42 23
METOPROLOL TARTRATE 76 26 42 19
TRIAMCINOLONE ACETONIDE 74 0 44 154
VIRAMUNE XR 73 22 45 394
FLUOXETINE HCL 72 13 46 65
INTELENCE 71 0 47 398
CARVEDILOL 67 18 48 14
GLYBURIDE 65 22 R 49 101
DAPSONE 64 18 50 410
SPIRONOLACTONE 64 0 50 53
MORPHINE SULFATE ER 62 0 S2 52 141
VENTOLIN HFA 62 0 52 91
TAMSULOSIN HCL 61 28 54 36
LATANOPROST 59 44 55 287
LABETALOL HCL 59 0 55 159
CLONIDINE HCL 58 0 57 28
MIRTAZAPINE 58 0 57 58
LEXIVA 57 0 59 424
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 16 60 26
FLUTICASONE PROPIONATE 55 0 61 41
HYDROXYZINE HCL 54 0 R 62 155
CYPROHEPTADINE HCL 54 0 R 62 242
GLIMEPIRIDE 51 0 64 30
EPIVIR 51 12 64 446
METOPROLOL SUCCINATE 50 21 66 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.